ID: ALA4061653

Max Phase: Preclinical

Molecular Formula: C19H20N2

Molecular Weight: 276.38

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  c1ccc(CNC2CCc3c([nH]c4ccccc34)C2)cc1

Standard InChI:  InChI=1S/C19H20N2/c1-2-6-14(7-3-1)13-20-15-10-11-17-16-8-4-5-9-18(16)21-19(17)12-15/h1-9,15,20-21H,10-13H2

Standard InChI Key:  KMOKEVFNTNVAQP-UHFFFAOYSA-N

Associated Targets(Human)

Retinoblastoma-associated protein 82 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 276.38Molecular Weight (Monoisotopic): 276.1626AlogP: 3.82#Rotatable Bonds: 3
Polar Surface Area: 27.82Molecular Species: BASEHBA: 1HBD: 2
#RO5 Violations: 0HBA (Lipinski): 2HBD (Lipinski): 2#RO5 Violations (Lipinski): 0
CX Acidic pKa: CX Basic pKa: 9.67CX LogP: 3.88CX LogD: 1.65
Aromatic Rings: 3Heavy Atoms: 21QED Weighted: 0.75Np Likeness Score: -0.45

References

1. Kulkarni MR, Mane MS, Ghosh U, Sharma R, Lad NP, Srivastava A, Kulkarni-Almeida A, Kharkar PS, Khedkar VM, Pandit SS..  (2017)  Discovery of tetrahydrocarbazoles as dual pERK and pRb inhibitors.,  134  [PMID:28431342] [10.1016/j.ejmech.2017.02.062]

Source